Ventricular cholinergic receptor systems: interaction with adrenergic systems.
D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D003714:Denervation; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010477:Perfusion; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013564:Sympathetic Nervous System; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D006584:Hexamethonium Compounds; D012110:Reserpine; D011433:Propranolol; D000109:Acetylcholine; D014403:Tubocurarine; D009638:Norepinephrine